Literature DB >> 11561157

Mouse models of acute promyelocytic leukemia.

J L Pollock1, P Westervelt, M J Walter, A A Lane, T J Ley.   

Abstract

Translocations involving a variety of fusion partners, such as promyelocytic leukemia gene, promyelocytic leukemia zinc finger, nucleophosmin, nuclear matrix protein, and signal transducer and activator of transcription protein 5B, with the retinoic acid receptor alpha gene are commonly associated with development of acute promyelocytic leukemia. Through the development of transgenic mouse models, some retinoic acid receptor alpha translocation fusion proteins have been shown to be capable of initiating acute promyelocytic leukemia development, and dictate the leukemias' responsiveness to retinoic acid. Transgenic mouse models also have identified the influence of reciprocal translocation fusion proteins on acute promyelocytic leukemia development, and have demonstrated that additional mutations can contribute to the development of acute promyelocytic leukemia. In this review, the authors summarize current mouse models of acute promyelocytic leukemia and describe current knowledge about additional genetic alterations that occur during development of acute promyelocytic leukemia in the mouse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561157     DOI: 10.1097/00062752-200107000-00005

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  6 in total

1.  Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance.

Authors:  Xuefang Cao; Karen Leonard; Lynne I Collins; Sheng F Cai; Joshua C Mayer; Jacqueline E Payton; Michael J Walter; David Piwnica-Worms; Robert D Schreiber; Timothy J Ley
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

2.  Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.

Authors:  John S Welch; Jeffery M Klco; Nobish Varghese; Rakesh Nagarajan; Timothy J Ley
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

3.  A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

Authors:  Timothy J Ley; Patrick J Minx; Matthew J Walter; Rhonda E Ries; Hui Sun; Michael McLellan; John F DiPersio; Daniel C Link; Michael H Tomasson; Timothy A Graubert; Howard McLeod; Hanna Khoury; Mark Watson; William Shannon; Kathryn Trinkaus; Sharon Heath; James W Vardiman; Michael A Caligiuri; Clara D Bloomfield; Jeffrey D Milbrandt; Elaine R Mardis; Richard K Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

4.  Location of NLS-RARα protein in NB4 cell and nude mice.

Authors:  Hui Wang; Rong Yang; Liang Zhong; Xin-Yu Zhu; Peng-Peng Ma; Xiao-Qun Yang; Kai-Ling Jiang; Bei-Zhong Liu
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

5.  The significance of low PU.1 expression in patients with acute promyelocytic leukemia.

Authors:  Xuehua Zhu; Hui Zhang; Maoxiang Qian; Xujie Zhao; Wentao Yang; Ping Wang; Ji Zhang; Kankan Wang
Journal:  J Hematol Oncol       Date:  2012-05-08       Impact factor: 17.388

6.  NLS-RARα promotes proliferation and inhibits differentiation in HL-60 cells.

Authors:  Xiu-Xiu Hu; Liang Zhong; Xi Zhang; Yuan-Mei Gao; Bei-Zhong Liu
Journal:  Int J Med Sci       Date:  2014-01-16       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.